EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype (Q38976788)

8 September 2017

title

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype (English)

1 reference

8 September 2017

1 reference

3

Aurélien de Reyniès

0 references

Sandra Rebouissou

Sandra Rebouissou

1

0 references

Mathilde Sibony

Mathilde Sibony

22

0 references

Eric Letouzé

Eric Letouzé

10

0 references

François Radvanyi

François Radvanyi

28

0 references

Simone Benhamou

Simone Benhamou

25

0 references

Jennifer Southgate

Jennifer Southgate

24

0 references

Fabien Reyal

20

Fabien Reyal

1 reference

8 September 2017

Elodie Chapeaublanc

6

0 references

author name string

Isabelle Bernard-Pierrot

2

1 reference

8 September 2017

May-Linda Lepage

4

1 reference

8 September 2017

Clémentine Krucker

5

1 reference

8 September 2017

Aurélie Hérault

7

1 reference

8 September 2017

Aurélie Kamoun

8

1 reference

8 September 2017

Aurélie Caillault

9

1 reference

8 September 2017

Nabila Elarouci

11

1 reference

8 September 2017

Yann Neuzillet

12

1 reference

8 September 2017

Yves Denoux

13

1 reference

8 September 2017

Vincent Molinié

14

1 reference

8 September 2017

Dimitri Vordos

15

1 reference

8 September 2017

Agnès Laplanche

16

1 reference

8 September 2017

Pascale Maillé

17

1 reference

8 September 2017

Pascale Soyeux

18

1 reference

8 September 2017

Karina Ofualuka

19

1 reference

8 September 2017

Anne Biton

21

1 reference

8 September 2017

Xavier Paoletti

23

1 reference

8 September 2017

Thierry Lebret

26

1 reference

8 September 2017

Yves Allory

27

1 reference

8 September 2017

language of work or name

English

0 references

publication date

1 July 2014

1 reference

Science Translational Medicine

8 September 2017

published in

1 reference

8 September 2017

volume

6

1 reference

8 September 2017

issue

244

1 reference

8 September 2017

page(s)

244ra91

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

New therapeutic challenges in advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Bladder cancer outcome and subtype classification by gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

A four-gene signature predicts disease progression in muscle invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

A molecular taxonomy for urothelial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Regional copy number-independent deregulation of transcription in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Basal breast cancer: a complex and deadly molecular subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Expression and functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Comprehensive molecular characterization of urothelial bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

A colorectal cancer classification system that associates cellular phenotype and responses to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Normal and neoplastic urothelial stem cells: getting to the root of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Selecting Differentially Expressed Genes from Microarray Experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3008970

10.1126/SCITRANSLMED.3008970

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference